Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment has been reported. - GreenMedInfo Summary

Abstract Title:

Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Abstract Source:

Clin Rheumatol. 2007 Feb;26(2):258-60. Epub 2006 Jul 6. PMID: 16683176

Abstract Author(s):

Maria G Tektonidou, John Serelis, Fotini N Skopouli

Article Affiliation:

Department of Internal Medicine, Euroclinic Hospital, 9 Athanasiadou str, 115 21, Athens, Greece. [email protected]

Abstract:

Antitumor necrosis alpha agents have been successfully used for the treatment of rheumatoid and seronegative arthritis, Crohn's disease, psoriasis, and severe cases of vasculitis. Several side effects have been observed in patients receiving these agents including hypersensitivity reactions, infections, drug-induced lupus, or demyelinating syndromes. The presence of peripheral neuropathy has been reported only in isolated cases. We describe two cases of peripheral neuropathy which occurred in patients with rheumatoid arthritis receiving infliximab treatment, one with multifocal motor neuropathy with conduction block and another with axonal sensory polyneuropathy, reversed upon discontinuation of infliximab and intravenous gammaglobulin treatment.

Article Published Date : Feb 01, 2007
Study Type : Human: Case Report
Additional Links
Diseases : Peripheral Neuropathies : CK(373) : AC(74)
Problem Substances : Infliximab : CK(45) : AC(8)
Adverse Pharmacological Actions : Neurotoxic : CK(2988) : AC(734)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.
  • Printer-friendly version

Key Research Topics

Disease

Peripheral Neuropathies

Toxic Ingredients

Infliximab

Adverse Pharmacological Actions

Neurotoxic

Connect with GreenMedInfo